[
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-07-22",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2026-07-16",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2026-07-09",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.87,
    "position_percent_raw": "0,87",
    "position_date": "2026-07-01",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-07-01",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2026-06-24",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.96,
    "position_percent_raw": "0,96",
    "position_date": "2026-06-23",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-06-17",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.07,
    "position_percent_raw": "1,07",
    "position_date": "2026-06-11",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-06-08",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2026-05-28",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2026-05-21",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2026-05-18",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.77,
    "position_percent_raw": "0,77",
    "position_date": "2026-05-08",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.1,
    "position_percent_raw": "1,1",
    "position_date": "2026-05-07",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.88,
    "position_percent_raw": "0,88",
    "position_date": "2026-05-07",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.98,
    "position_percent_raw": "0,98",
    "position_date": "2026-05-04",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2026-04-30",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2026-04-28",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.02,
    "position_percent_raw": "1,02",
    "position_date": "2026-04-27",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.08,
    "position_percent_raw": "1,08",
    "position_date": "2026-04-24",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.18,
    "position_percent_raw": "1,18",
    "position_date": "2026-04-23",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.16,
    "position_percent_raw": "1,16",
    "position_date": "2026-04-23",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2026-04-23",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.24,
    "position_percent_raw": "1,24",
    "position_date": "2026-04-21",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.27,
    "position_percent_raw": "1,27",
    "position_date": "2026-04-21",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.6,
    "position_percent_raw": "1,6",
    "position_date": "2026-04-16",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.39,
    "position_percent_raw": "1,39",
    "position_date": "2026-04-16",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.34,
    "position_percent_raw": "1,34",
    "position_date": "2026-04-16",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.51,
    "position_percent_raw": "1,51",
    "position_date": "2026-04-13",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.47,
    "position_percent_raw": "1,47",
    "position_date": "2026-04-13",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2026-04-10",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.58,
    "position_percent_raw": "1,58",
    "position_date": "2026-04-08",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2026-04-08",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.96,
    "position_percent_raw": "0,96",
    "position_date": "2026-04-01",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.78,
    "position_percent_raw": "0,78",
    "position_date": "2026-03-30",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.8,
    "position_percent_raw": "0,8",
    "position_date": "2026-03-27",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.1,
    "position_percent_raw": "1,1",
    "position_date": "2026-03-26",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.01,
    "position_percent_raw": "1,01",
    "position_date": "2026-03-23",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2026-03-20",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.98,
    "position_percent_raw": "0,98",
    "position_date": "2026-03-06",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.71,
    "position_percent_raw": "0,71",
    "position_date": "2026-03-04",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2026-02-20",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.63,
    "position_percent_raw": "1,63",
    "position_date": "2026-02-13",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.51,
    "position_percent_raw": "0,51",
    "position_date": "2026-02-12",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.59,
    "position_percent_raw": "1,59",
    "position_date": "2026-02-12",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.01,
    "position_percent_raw": "1,01",
    "position_date": "2026-02-11",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.41,
    "position_percent_raw": "1,41",
    "position_date": "2026-02-09",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.94,
    "position_percent_raw": "0,94",
    "position_date": "2026-02-06",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.53,
    "position_percent_raw": "1,53",
    "position_date": "2026-02-03",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.42,
    "position_percent_raw": "1,42",
    "position_date": "2026-01-30",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2026-01-29",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.49,
    "position_percent_raw": "1,49",
    "position_date": "2026-01-28",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.75,
    "position_percent_raw": "0,75",
    "position_date": "2026-01-28",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.38,
    "position_percent_raw": "1,38",
    "position_date": "2026-01-27",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.83,
    "position_percent_raw": "0,83",
    "position_date": "2026-01-27",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.31,
    "position_percent_raw": "1,31",
    "position_date": "2026-01-27",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2026-01-26",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.91,
    "position_percent_raw": "0,91",
    "position_date": "2026-01-26",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.2,
    "position_percent_raw": "1,2",
    "position_date": "2026-01-22",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2026-01-15",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.12,
    "position_percent_raw": "1,12",
    "position_date": "2026-01-14",
    "comment": ""
  },
  {
    "holder": "MILLENNIUM INTERNATIONAL MANAGEMENT LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-01-13",
    "comment": ""
  },
  {
    "holder": "BlackRock Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-01-13",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2026-01-07",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.01,
    "position_percent_raw": "1,01",
    "position_date": "2026-01-07",
    "comment": ""
  },
  {
    "holder": "MILLENNIUM INTERNATIONAL MANAGEMENT LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-12-30",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-12-22",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.93,
    "position_percent_raw": "0,93",
    "position_date": "2025-12-18",
    "comment": ""
  },
  {
    "holder": "MILLENNIUM INTERNATIONAL MANAGEMENT LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-12-17",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.68,
    "position_percent_raw": "0,68",
    "position_date": "2025-12-17",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2025-12-12",
    "comment": ""
  },
  {
    "holder": "MILLENNIUM INTERNATIONAL MANAGEMENT LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-12-10",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-12-10",
    "comment": ""
  },
  {
    "holder": "AQR Capital Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-12-04",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.73,
    "position_percent_raw": "0,73",
    "position_date": "2025-12-03",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.89,
    "position_percent_raw": "0,89",
    "position_date": "2025-12-02",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-11-26",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.57,
    "position_percent_raw": "0,57",
    "position_date": "2025-11-14",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2025-10-30",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.28,
    "position_percent_raw": "1,28",
    "position_date": "2025-10-29",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.05,
    "position_percent_raw": "1,05",
    "position_date": "2025-10-28",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.97,
    "position_percent_raw": "0,97",
    "position_date": "2025-10-27",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.08,
    "position_percent_raw": "1,08",
    "position_date": "2025-10-27",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-10-20",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.11,
    "position_percent_raw": "1,11",
    "position_date": "2025-10-20",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.67,
    "position_percent_raw": "0,67",
    "position_date": "2025-10-17",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2025-10-14",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-10-13",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2025-10-13",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.83,
    "position_percent_raw": "0,83",
    "position_date": "2025-10-10",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.86,
    "position_percent_raw": "0,86",
    "position_date": "2025-10-08",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.97,
    "position_percent_raw": "0,97",
    "position_date": "2025-10-07",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.95,
    "position_percent_raw": "0,95",
    "position_date": "2025-10-06",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.58,
    "position_percent_raw": "0,58",
    "position_date": "2025-10-02",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2025-10-02",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2025-10-02",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2025-09-30",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.93,
    "position_percent_raw": "0,93",
    "position_date": "2025-09-30",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-09-29",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-09-24",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.52,
    "position_percent_raw": "0,52",
    "position_date": "2025-09-24",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2025-09-23",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2025-09-23",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-09-22",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.98,
    "position_percent_raw": "0,98",
    "position_date": "2025-09-19",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.36,
    "position_percent_raw": "1,36",
    "position_date": "2025-09-18",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.07,
    "position_percent_raw": "1,07",
    "position_date": "2025-09-12",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-09-10",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.78,
    "position_percent_raw": "0,78",
    "position_date": "2025-09-08",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-09-05",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-09-05",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-09-05",
    "comment": ""
  },
  {
    "holder": "BlackRock Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-09-02",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.14,
    "position_percent_raw": "1,14",
    "position_date": "2025-09-01",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-08-28",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.89,
    "position_percent_raw": "0,89",
    "position_date": "2025-08-28",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.45,
    "position_percent_raw": "1,45",
    "position_date": "2025-08-27",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.03,
    "position_percent_raw": "1,03",
    "position_date": "2025-08-27",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2025-08-27",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-08-18",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2025-08-18",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-08-15",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-08-14",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-08-12",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-08-11",
    "comment": ""
  },
  {
    "holder": "Winton Capital Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-08-08",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2025-08-07",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.71,
    "position_percent_raw": "0,71",
    "position_date": "2025-08-06",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.68,
    "position_percent_raw": "0,68",
    "position_date": "2025-08-05",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-08-05",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-08-04",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.32,
    "position_percent_raw": "1,32",
    "position_date": "2025-08-01",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-07-31",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.61,
    "position_percent_raw": "0,61",
    "position_date": "2025-07-31",
    "comment": ""
  },
  {
    "holder": "Acadian Asset Management LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.55,
    "position_percent_raw": "0,55",
    "position_date": "2025-07-30",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2025-07-29",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.63,
    "position_percent_raw": "0,63",
    "position_date": "2025-07-29",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-07-24",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2025-07-16",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.74,
    "position_percent_raw": "0,74",
    "position_date": "2025-07-15",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.73,
    "position_percent_raw": "0,73",
    "position_date": "2025-07-14",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.65,
    "position_percent_raw": "0,65",
    "position_date": "2025-07-14",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.29,
    "position_percent_raw": "1,29",
    "position_date": "2025-07-11",
    "comment": ""
  },
  {
    "holder": "D E Shaw Co LP",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-07-11",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.87,
    "position_percent_raw": "0,87",
    "position_date": "2025-07-11",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-07-03",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2025-06-30",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.61,
    "position_percent_raw": "0,61",
    "position_date": "2025-06-25",
    "comment": ""
  },
  {
    "holder": "Marchant MC Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.54,
    "position_percent_raw": "0,54",
    "position_date": "2025-06-24",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.93,
    "position_percent_raw": "0,93",
    "position_date": "2025-06-23",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.63,
    "position_percent_raw": "0,63",
    "position_date": "2025-06-18",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.51,
    "position_percent_raw": "0,51",
    "position_date": "2025-06-11",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.8,
    "position_percent_raw": "0,8",
    "position_date": "2025-04-08",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.67,
    "position_percent_raw": "0,67",
    "position_date": "2025-04-07",
    "comment": ""
  },
  {
    "holder": "JPMorgan Asset Management (UK) Ltd",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": 0.55,
    "position_percent_raw": "0,55",
    "position_date": "2025-04-04",
    "comment": ""
  },
  {
    "holder": "Franklin Templeton Investment Management Limited",
    "issuer": "Xvivo Perfusion Aktiebolag",
    "isin": "SE0004840718",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2024-08-23",
    "comment": ""
  }
]